 |
| 4.06.2016 | AGENDA |
| | . |
| 12:30 – 1:30 | Registration & Networking |
| 1:30 – 1:45 | Welcome & Opening Remarks
Al Sandrock, Chief Medical Officer, Biogen
Bob Buderi, Founder, CEO, and Editor in Chief, Xconomy |
| 1:45 – 2:15 | Neoantigens and the Next Wave of Cancer Vaccines
Cary Pfeffer, Partner, Third Rock Ventures
Nir Hacohen, Co-founder, Neon Therapeutics; Director, MGH Center for Immunotherapy
Samantha Singer, COO, The Broad Institute (moderator) |
| 2:15 – 2:30 | Spotlight Talk: Biotech Game Theory
Peter Kolchinsky, Founder & Managing Director, RA Capital |
| 2:30 – 3:00 | Innovative Approaches to Neuroscience
Deborah Dunsire, CEO, Forum Pharmaceuticals
Al Sandrock, Chief Medical Officer, Biogen
Daphne Zohar, CEO, PureTech Health
Jens Eckstein, President, SR One (moderator) |
| 3:00 – 3:30 | Networking Break |
| 3:30 – 4:00 | NASH and Nimbus: Combating the Looming Liver Disease Epidemic
Bruce Booth, Partner, Atlas Venture
Don Nicholson, CEO, Nimbus Therapeutics |
| 4:00 – 4:15 | Spotlight Talk: The Druggability Gap
Gregory Verdine, Founder & CSO, Warp Drive Bio; Professor, Harvard University |
| 4:15 – 4:45 | Biology Meets Engineering
Phillip A. Sharp, Nobel Laureate; Institute Professor, MIT
Robert Urban, Head, Johnson & Johnson Innovation, Boston (moderator) |
| 4:45 – 5:15 | Drug Pricing and Innovation: Combating Healthcare’s Biggest Challenge
Peter Hecht, CEO, Ironwood Pharmaceuticals
Tillman U. Gerngross, Professor of Bioengineering, Dartmouth College
Marc Rubenstein, Partner, Ropes & Gray (moderator) |
| 5:15 – 6:30 | Networking Reception |
